Page 39 - Human Use News Today

The European Commission has approved brentuximab vedotin in combination with doxorubicin, vinblastine, and dacarbazine for the treatment of adult patients with previously untreated, CD30-positive, stage III Hodgkin lymphoma.

FDA approval of ZILBRYSQ® (zilucoplan) has been granted for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-ac...

UCB announces U.S. FDA approval of ZILBRYSQ[®] for the treatment of adults with generalized myasthenia gravis FDA approval of ZILBRYSQ® has been granted...

Regulators in the United Kingdom have approved full marketing authorization for Maryland-based Novavax’s updated, protein-based COVID-19 booster shot, but regulators in the European Union have delayed a decision.

RAHWAY, N.J.--(BUSINESS WIRE)--Oct 17, 2023--

The European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted a positive opinion regarding the approval of a Type II variation application for rucaparib as a frontline maintenance in patients with advanced ovarian cancer who have responded to first-line, platinum-based chemotherapy, irrespective of BRCA mutational status.

FDA approval of ZILBRYSQ® has been granted for the treatment of generalized myasthenia gravis in adult patients who are anti-acetylcholine receptor antibody-positive1ZILBRYSQ is the first...

GSK positive CHMP opinion recommending Jemperli plus chemotherapy to treat endometrial cancer

The FTSE 100 is likely to open higher on Monday, benefitting from higher oil and gas prices, while fears of escalating regional conflict in the Middle East damp risk sentiment elsewhere. More than...

FTSE 100 up 33 points at 7,632 Shells share price hits all-time high Ocado falls as Barclays downgrades 1:01pm: UK to avoid recession but growth sluggish...